This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, H.-S.
Right arrow Articles by Colburn, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, H.-S.
Right arrow Articles by Colburn, N. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2003, p. 26-37, Vol. 23, No. 1
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.1.26-37.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

Hsin-Sheng Yang,1* Aaron P. Jansen,1 Anton A. Komar,2 Xiaojing Zheng,2 William C. Merrick,2 Sylvain Costes,3 Stephen J. Lockett,3 Nahum Sonenberg,4 and Nancy H. Colburn1

Gene Regulation Section, Center for Cancer Research,1 Image Analysis Laboratory, Science Applications International Corporation, National Cancer Institute, Frederick, Maryland 21702,3 Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4935,2 Department of Biochemistry and McGill Cancer Research Centre, University of McGill, Montreal, Quebec H3G 1Y6, Canada4

Received 26 August 2002/ Returned for modification 19 September 2002/ Accepted 2 October 2002

Pdcd4 is a novel transformation suppressor that inhibits tumor promoter-induced neoplastic transformation and the activation of AP-1-dependent transcription required for transformation. A yeast two-hybrid analysis revealed that Pdcd4 associates with the eukaryotic translation initiation factors eIF4AI and eIF4AII. Immunofluorescent confocal microscopy showed that Pdcd4 colocalizes with eIF4A in the cytoplasm. eIF4A is an ATP-dependent RNA helicase needed to unwind 5' mRNA secondary structure. Recombinant Pdcd4 specifically inhibited the helicase activity of eIF4A and eIF4F. In vivo translation assays showed that Pdcd4 inhibited cap-dependent but not internal ribosome entry site (IRES)-dependent translation. In contrast, Pdcd4D418A, a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation. Recombinant Pdcd4 prevented eIF4A from binding to the C-terminal region of eIF4G (amino acids 1040 to 1560) but not to the middle region of eIF4G(amino acids 635 to 1039). In addition, both Pdcd4 and Pdcd4D418A bound to the middle region of eIF4G. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.


* Corresponding author. Mailing address: Gene Regulation Section, Bldg. 567, Rm. 180, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702. Phone: (301) 846-6564. Fax: (301) 846-6907. E-mail: hyang{at}ncifcrf.gov.


Molecular and Cellular Biology, January 2003, p. 26-37, Vol. 23, No. 1
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.1.26-37.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bourguignon, L. Y. W., Spevak, C. C., Wong, G., Xia, W., Gilad, E. (2009). Hyaluronan-CD44 Interaction with Protein Kinase C{epsilon} Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells. J. Biol. Chem. 284: 26533-26546 [Abstract] [Full Text]  
  • Eto, K., Eda, K., Hayano, M., Goto, S., Nagao, K., Kawasaki, T., Kashimura, H., Tarui, H., Nishimura, O., Agata, K., Abe, S.-i. (2009). Reduced Expression of an RNA-binding Protein by Prolactin Leads to Translational Silencing of Programmed Cell Death Protein 4 and Apoptosis in Newt Spermatogonia. J. Biol. Chem. 284: 23260-23271 [Abstract] [Full Text]  
  • Yamamichi, N., Shimomura, R., Inada, K.-i., Sakurai, K., Haraguchi, T., Ozaki, Y., Fujita, S., Mizutani, T., Furukawa, C., Fujishiro, M., Ichinose, M., Shiogama, K., Tsutsumi, Y., Omata, M., Iba, H. (2009). Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development. Clin. Cancer Res. 15: 4009-4016 [Abstract] [Full Text]  
  • Lin, C.-J., Sukarieh, R., Pelletier, J. (2009). Silibinin inhibits translation initiation: implications for anticancer therapy. Molecular Cancer Therapeutics 8: 1606-1612 [Abstract] [Full Text]  
  • Khoshnaw, S M, Green, A R, Powe, D G, Ellis, I O (2009). MicroRNA involvement in the pathogenesis and management of breast cancer. J. Clin. Pathol. 62: 422-428 [Abstract] [Full Text]  
  • Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., Yasuniwa, Y., Naito, S., Nishizawa, S., Sasaguri, Y., Kohno, K. (2009). Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth. Cancer Res. 69: 3148-3156 [Abstract] [Full Text]  
  • Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., Yoshida, N., Toyama, E., Hayashi, N., Watanabe, M., Baba, H. (2009). MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Clin. Cancer Res. 15: 1915-1922 [Abstract] [Full Text]  
  • Chang, J. H., Cho, Y. H., Sohn, S. Y., Choi, J. M., Kim, A., Kim, Y. C., Jang, S. K., Cho, Y. (2009). Crystal structure of the eIF4A-PDCD4 complex. Proc. Natl. Acad. Sci. USA 106: 3148-3153 [Abstract] [Full Text]  
  • Woodard, J., Sassano, A., Hay, N., Platanias, L. C. (2008). Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma. Clin. Cancer Res. 14: 4640-4649 [Abstract] [Full Text]  
  • Carayol, N., Katsoulidis, E., Sassano, A., Altman, J. K., Druker, B. J., Platanias, L. C. (2008). Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway. J. Biol. Chem. 283: 8601-8610 [Abstract] [Full Text]  
  • Suzuki, C., Garces, R. G., Edmonds, K. A., Hiller, S., Hyberts, S. G., Marintchev, A., Wagner, G. (2008). PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc. Natl. Acad. Sci. USA 105: 3274-3279 [Abstract] [Full Text]  
  • Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., Lund, A. H. (2008). Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells. J. Biol. Chem. 283: 1026-1033 [Abstract] [Full Text]  
  • LaRonde-LeBlanc, N., Santhanam, A. N., Baker, A. R., Wlodawer, A., Colburn, N. H. (2007). Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4. Mol. Cell. Biol. 27: 147-156 [Abstract] [Full Text]  
  • Ozpolat, B., Akar, U., Steiner, M., Zorrilla-Calancha, I., Tirado-Gomez, M., Colburn, N., Danilenko, M., Kornblau, S., Lopez Berestein, G. (2007). Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells. Mol Cancer Res 5: 95-108 [Abstract] [Full Text]  
  • Hilliard, A., Hilliard, B., Zheng, S.-J., Sun, H., Miwa, T., Song, W., Goke, R., Chen, Y. H. (2006). Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4. J. Immunol. 177: 8095-8102 [Abstract] [Full Text]  
  • Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., Pagano, M. (2006). S6K1- and {beta}TRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth.. Science 314: 467-471 [Abstract] [Full Text]  
  • Reinert, L. S., Shi, B., Nandi, S., Mazan-Mamczarz, K., Vitolo, M., Bachman, K. E., He, H., Gartenhaus, R. B. (2006). MCT-1 Protein Interacts with the Cap Complex and Modulates Messenger RNA Translational Profiles.. Cancer Res. 66: 8994-9001 [Abstract] [Full Text]  
  • Shigenobu, S., Kitadate, Y., Noda, C., Kobayashi, S. (2006). Molecular characterization of embryonic gonads by gene expression profiling in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 103: 13728-13733 [Abstract] [Full Text]  
  • Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., Colburn, N. H. (2006). Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion. Mol. Cell. Biol. 26: 1297-1306 [Abstract] [Full Text]  
  • Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R. I., Croce, C. M., Pekarsky, Y. (2005). Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein. Cancer Res. 65: 11282-11286 [Abstract] [Full Text]  
  • Bonome, T., Lee, J.-Y., Park, D.-C., Radonovich, M., Pise-Masison, C., Brady, J., Gardner, G. J., Hao, K., Wong, W. H., Barrett, J. C., Lu, K. H., Sood, A. K., Gershenson, D. M., Mok, S. C., Birrer, M. J. (2005). Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the Ovary. Cancer Res. 65: 10602-10612 [Abstract] [Full Text]  
  • Oberer, M., Marintchev, A., Wagner, G. (2005). Structural basis for the enhancement of eIF4A helicase activity by eIF4G. Genes Dev. 19: 2212-2223 [Abstract] [Full Text]  
  • Bordeleau, M.-E., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., Pelletier, J. (2005). Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. USA 102: 10460-10465 [Abstract] [Full Text]  
  • Jansen, A. P., Camalier, C. E., Colburn, N. H. (2005). Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis. Cancer Res. 65: 6034-6041 [Abstract] [Full Text]  
  • Bader, A. G., Vogt, P. K. (2005). Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation. Mol. Cell. Biol. 25: 2095-2106 [Abstract] [Full Text]  
  • ZAKOWICZ, H., YANG, H.-S., STARK, C., WLODAWER, A., LARONDE-LEBLANC, N., COLBURN, N. H. (2005). Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA 11: 261-274 [Abstract] [Full Text]  
  • Korneeva, N. L., First, E. A., Benoit, C. A., Rhoads, R. E. (2005). Interaction between the NH2-terminal Domain of eIF4A and the Central Domain of eIF4G Modulates RNA-stimulated ATPase Activity. J. Biol. Chem. 280: 1872-1881 [Abstract] [Full Text]  
  • Goke, R., Barth, P., Schmidt, A., Samans, B., Lankat-Buttgereit, B. (2004). Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1. Am. J. Physiol. Cell Physiol. 287: C1541-C1546 [Abstract] [Full Text]  
  • Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., Colburn, N. H. (2004). A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A. Mol. Cell. Biol. 24: 3894-3906 [Abstract] [Full Text]  
  • Jansen, A. P., Camalier, C. E., Stark, C., Colburn, N. H. (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Molecular Cancer Therapeutics 3: 103-110 [Abstract] [Full Text]